Study guide

12.1 Antenatal Care, Maternal Nutrition & Fetal Assessment

Combined Medical Services Examination UPSC CMS

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Structure, Logistics & Pattern

1.1 UPSC CMS Examination Overview & Eligibility 1.2 Two-Paper Written Exam Pattern & Negative Marking 1.3 Personality Test, Service Allocation & Career Paths

2 Chapter 2: General Medicine - Cardiology & Respiratory

2.1 Coronary Artery Disease & Acute Myocardial Infarction 2.2 Heart Failure & Cardiac Arrhythmias 2.3 Community-Acquired Pneumonia & Pulmonary Tuberculosis 2.4 COPD, Bronchial Asthma & Pulmonary Embolism

3 Chapter 3: General Medicine - Gastroenterology & Hepatology

3.1 Peptic Ulcer Disease & Upper GI Bleeding 3.2 Liver Cirrhosis & Portal Hypertension 3.3 Acute & Chronic Viral Hepatitis & Pancreatitis 3.4 Inflammatory Bowel Disease & Malabsorption Syndromes

4 Chapter 4: General Medicine - Nephrology & Endocrinology

4.1 Acute Kidney Injury & Chronic Kidney Disease 4.2 Glomerulonephritis, Nephrotic Syndrome & Electrolyte Imbalances 4.3 Diabetes Mellitus: Diagnosis, Complications & Management 4.4 Thyroid Disorders & Adrenal Gland Dysfunction

5 Chapter 5: General Medicine - Neurology, Haematology & Infection

5.1 Cerebrovascular Accidents (Stroke) & Epilepsy 5.2 Approach to Anaemia: Microcytic, Megaloblastic & Haemolytic 5.3 Acute & Chronic Leukaemias and Lymphomas 5.4 Tropical & Endemic Infections: Malaria, Typhoid & Dengue

6 Chapter 6: General Medicine - Emergency Medicine & Toxicology

6.1 Acute Anaphylaxis, Sepsis & Cardiopulmonary Resuscitation 6.2 Organophosphate, Paracetamol & Snakebite Toxicology 6.3 Common Dermatological & Psychiatric Manifestations in Internal Medicine 6.4 Musculoskeletal System & Adult Rheumatology

7 Chapter 7: Paediatrics - Neonatology & Child Growth

7.1 Newborn Care, Neonatal Resuscitation & APGAR Score 7.2 Prematurity, Low Birth Weight & Neonatal Jaundice 7.3 Infant & Child Growth & Developmental Milestones

8 Chapter 8: Paediatrics - Child Health & Nutrition

8.1 Protein-Energy Malnutrition (PEM) & Micronutrient Deficiencies 8.2 Universal Immunization Programme (UIP) & Child Vaccines 8.3 Pediatric Diarrhoea, Dehydration & Respiratory Emergencies 8.4 Birth Defects, Genetic Counseling, Autism & Paediatric Accidents/Poisoning

9 Chapter 9: Surgery - General Surgery, Wounds & Shock

9.1 Wound Healing, Surgical Site Infections & Gas Gangrene 9.2 Pathophysiology of Shock & Perioperative Fluid Therapy 9.3 Acute Abdomen: Appendicitis, Peritonitis & Intestinal Obstruction 9.4 Classification, Resuscitation & Management of Thermal Burns 9.5 Medicolegal & Ethical Issues in Surgery

10 Chapter 10: Surgery - Surgical Specialties I

10.1 Inguinal, Femoral & Ventral Hernias 10.2 Benign Breast Diseases & Breast Carcinoma 10.3 Solitary Thyroid Nodule & Thyroid Carcinoma 10.4 Benign Prostatic Hyperplasia & Renal Calculi

11 Chapter 11: Surgery - ENT, Orthopaedics & Anaesthesia

11.1 Acute Otitis Media, Tonsillitis & Epistaxis 11.2 Cataract, Glaucoma & Red Eye Emergencies 11.3 Principles of Fracture Management & Common Dislocation 11.4 Principles of Local, Regional & General Anaesthesia 11.5 Neurosurgery: Raised ICP, Head Injury & CNS Lesions 11.6 Thoracic Surgery: Chest Trauma, Pleural & Lung Disease

12 Chapter 12: Obstetrics - Antenatal Care & Complications

12.1 Antenatal Care, Maternal Nutrition & Fetal Assessment 12.2 Preeclampsia, Eclampsia & Gestational Hypertension 12.3 Antepartum Haemorrhage: Placenta Previa & Abruptio Placentae 12.4 Anemia in Pregnancy & Gestational Diabetes Mellitus 12.5 Spontaneous & Recurrent Abortion: Recognition & Management

13 Chapter 13: Obstetrics & Gynaecology - Labor & PPH

13.1 Normal Labor Mechanisms & Partograph Monitoring 13.2 Malpresentations, Breech & Obstructed Labor 13.3 Postpartum Haemorrhage (PPH) Causes & Management 13.4 Puerperal Sepsis & Postnatal Maternal Care

14 Chapter 14: Gynaecology & Family Planning

14.1 Abnormal Uterine Bleeding & Uterine Fibroids 14.2 Cervical Screening (Pap Smear) & Pelvic Inflammatory Disease 14.3 Temporary & Permanent Contraceptive Methods in India 14.4 Medical Termination of Pregnancy (MTP): Law & Methods

15 Chapter 15: PSM - Epidemiology & Biostatistics

15.1 Principles of Epidemiology & Disease Transmission 15.2 Observational & Experimental Epidemiological Study Designs 15.3 Evaluation of Screening Tests: Sensitivity, Specificity & Predictive Value 15.4 Biostatistics: Sampling, Central Tendency & Significance Testing

16 Chapter 16: PSM - Disease Epidemiology & Programmes

16.1 Epidemiology & Control of TB, Malaria & Dengue 16.2 National Tuberculosis Elimination Programme & NVBDCP 16.3 Epidemiology of Hypertension, Diabetes & Cancer in India 16.4 Cold Chain Management & Vaccine Logistics in India 16.5 Genetics and Health: Inheritance, Screening & Counseling

17 Chapter 17: PSM - Health Planning & Environmental Health

17.1 Demography, Fertility Rates & Family Welfare Indicators 17.2 Safe Water Supply, Waste Disposal & Air Pollution 17.3 Occupational Health Hazards & Pneumoconioses 17.4 Health Care Delivery System, Ayushman Bharat & National Health Mission 17.5 International Health: WHO, Global Agencies & SDG 3 17.6 Medical Sociology & Health Education

12.1 Antenatal Care, Maternal Nutrition & Fetal Assessment

Key Takeaways Explain This Topic AI

WHO recommends a minimum of 8 antenatal contacts, while traditional models require at least 4 visits (at <12 weeks, 14-26 weeks, 28-34 weeks, and 36-40 weeks).

Naegele's rule calculates the Expected Date of Delivery (EDD) by adding 7 days and 9 months to the first day of the Last Menstrual Period (LMP).

Prophylactic iron (60 mg elemental iron + 500 mcg folic acid daily for 180 days) and periconceptional folic acid (400 mcg standard, 5 mg for high-risk) prevent maternal anemia and neural tube defects.

Quadruple marker screening for Down syndrome reveals elevated hCG and Inhibin-A with decreased AFP and unconjugated estriol (uE3).

Fetal biophysical profile (Manning score) evaluates 5 parameters (NST, breathing, movement, tone, amniotic fluid volume), where amniotic fluid volume reflects chronic placental function.

Last updated: July 2026

12.1 Antenatal Care, Maternal Nutrition & Fetal Assessment

Antenatal care (ANC) encompasses systemic, periodic medical supervision of women during pregnancy to ensure optimal maternal and fetal health outcomes. The primary objectives of antenatal care are the early identification and management of high-risk obstetric conditions, promotion of maternal nutritional well-being, prevention of vertical transmission of infections, and reduction of maternal and perinatal morbidity and mortality.

1. Antenatal Visit Schedules & Models

Historically, the traditional schedule of antenatal visits comprised monthly visits up to 28 weeks of gestation, fortnightly visits from 28 to 36 weeks, and weekly visits from 36 weeks until delivery (totaling approximately 12–14 visits).

WHO Focused Antenatal Care (FANC) vs. 2016 Recommendations

Traditional 4-Visit Minimum Model (WHO FANC):

First Visit: < 12 weeks (Registration, baseline investigations, dating, folic acid initiation).

Second Visit: 14–26 weeks (Screening for preeclampsia, fetal anomaly scan at 18–22 weeks, Td vaccination).

Third Visit: 28–34 weeks (Screening for anemia, gestational diabetes, fetal growth assessment, Td second dose).

Fourth Visit: 36–40 weeks (Assessment of fetal presentation, position, pelvis, and delivery planning).

WHO 2016 Comprehensive Model: Recommends a minimum of 8 antenatal contacts (at 12, 20, 26, 30, 34, 36, 38, and 40 weeks) to significantly reduce perinatal mortality and improve maternal health satisfaction.

Pradhan Mantri Surakshit Matritva Abhiyan (PMSMA): A national initiative in India providing fixed-day, free, comprehensive antenatal check-ups on the 9th of every month by obstetricians and specialists for pregnant women in their 2nd and 3rd trimesters.

2. Clinical Estimation of Gestational Age & Symphysio-Fundal Height

Naegele's Rule for Expected Date of Delivery (EDD) EDD = First Day of LMP + 7 Days + 9 Calendar Months \text{EDD} = \text{First Day of LMP} + 7 \text{ Days} + 9 \text{ Calendar Months} EDD = First Day of LMP + 7 Days + 9 Calendar Months

(Alternatively: LMP + 1 Year - 3 Months + 7 Days)

Prerequisites: Valid only for women with regular 28-day menstrual cycles. If the cycle length is longer (e.g., 32 days), add the extra days (e.g., +11 days instead of +7 days).

Milestones of Fundal Height Examination

Palpation of the uterine fundus provides a rapid clinical estimate of fetal growth and gestational age:

  • Gestational Age Location of Uterine Fundus
  • 12 Weeks Just palpable at the upper border of the pubic symphysis
  • 16 Weeks Midway between the pubic symphysis and the umbilicus
  • 20 Weeks 2 cm (two fingerbreadths) below the umbilicus
  • 24 Weeks At the level of the umbilicus
  • 28 Weeks Junction of the lower 1/3 and upper 2/3 between umbilicus and xiphisternum
  • 32 Weeks Midway between the umbilicus and the xiphisternum
  • 36 Weeks At the level of the xiphoid process (highest level reached)
  • 40 Weeks Drops down to the level of 32 weeks due to engagement of the head ("Lightening")

Differential Diagnosis of 32 vs. 40 Weeks Fundal Height: Both present with fundal height at the midway point between umbilicus and xiphoid. At 40 weeks , the fetal head is engaged, the flanks are full, and the abdomen is prominent anteriorly. At 32 weeks , the fetal head is unengaged, flanks are empty, and the girth is smaller.

McDonald's Rule

From 20 to 36 weeks of gestation, the Symphysio-Fundal Height (SFH) measured in centimeters using a tape measure over the abdominal curve corresponds directly to the gestational age in weeks ( ± 2 cm \pm 2\text{ cm} ± 2 cm ). Gestational Age (in Months) = SFH in cm × 2 7 \text{Gestational Age (in Months)} = \frac{\text{SFH in cm} \times 2}{7} Gestational Age (in Months) = 7 SFH in cm × 2 ​ Gestational Age (in Weeks) = SFH in cm × 8 7 \text{Gestational Age (in Weeks)} = \frac{\text{SFH in cm} \times 8}{7} Gestational Age (in Weeks) = 7 SFH in cm × 8 ​

  • 3. Maternal Nutrition, Micronutrients & Immunization
  • Nutritional Requirements in Pregnancy

Caloric Intake: Additional +350 kcal/day during the 2nd and 3rd trimesters (ICMR guidelines).

Protein Intake: Additional +23 g/day of protein.

Weight Gain Goals: Normal BMI (18.5–24.9): 11.5–16 kg total weight gain. Underweight (<18.5): 12.5–18 kg. Overweight (25–29.9): 7–11.5 kg. Obese (≥30): 5–9 kg.

Micronutrient Supplementation Protocols

Folic Acid:

Standard Prophylaxis: 400 mcg (0.4 mg) daily starting periconceptionally (3 months before conception) through 12 weeks of gestation to reduce Neural Tube Defects (NTD) such as anencephaly and spina bifida by >70%.

High-Risk Dose: 5 mg daily for women with a prior child with NTD, maternal pre-gestational diabetes, or women taking anti-epileptic drugs (valproic acid, carbamazepine).

Iron & Folic Acid (IFA) under Anemia Mukt Bharat:

Prophylaxis: 60 mg elemental iron + 500 mcg folic acid daily for 180 days, starting from the 2nd trimester (14 weeks onwards).

Calcium & Vitamin D3:

Prophylaxis: 1000 mg (1 g) elemental calcium + 250–400 IU Vitamin D3 daily starting from 14 weeks onwards (given as two doses of 500 mg calcium). Iron and calcium supplements must never be ingested simultaneously, as calcium inhibits non-heme iron absorption.

Tetanus and Diphtheria (Td) Immunization:

Td-1: Early in pregnancy (as soon as registered).

Td-2: 4 weeks after Td-1.

Td Booster: Single dose if the woman received two doses of Td in a pregnancy within the preceding 3 years.

  • 4. Screening for Fetal Aneuploidies & Structural Anomalies
  • First-Trimester Combined Screening (11 to 13+6 Weeks)

Ultrasound Marker: Nuchal Translucency (NT) thickness (normal < 3.0 mm). Increased NT (≥3.0 mm) is associated with Trisomy 21 (Down syndrome), Trisomy 18, Trisomy 13, Turner syndrome, and congenital heart defects.

Serum Markers: Elevated free β \beta β -hCG + Decreased Pregnancy-Associated Plasma Protein A (PAPP-A).

Detection Rate: ~85–90% for Down syndrome.

Second-Trimester Quadruple Marker Screening (15 to 20 Weeks)

Measures four maternal serum analytes to risk-stratify for chromosomal anomalies and neural tube defects:

Condition Maternal Serum AFP Human Chorionic Gonadotropin (hCG) Unconjugated Estriol ( u E 3 uE_3 u E 3 ​ ) Inhibin-A

Trisomy 21 (Down) Low ( ↓ \downarrow ↓ ) Elevated ( ↑ ↑ \uparrow\uparrow ↑↑ ) Low ( ↓ \downarrow ↓ ) Elevated ( ↑ ↑ \uparrow\uparrow ↑↑ )

  • Trisomy 18 (Edwards) Low ( ↓ \downarrow ↓ ) Low ( ↓ \downarrow ↓ ) Low ( ↓ \downarrow ↓ ) Unchanged / Low
  • Open NTDs / Omphalocele Markedly Elevated ( ↑ ↑ ↑ \uparrow\uparrow\uparrow ↑↑↑ ) Normal Normal Normal

Memory Aid for Down Syndrome (Trisomy 21): "HI is High" — H CG and I nhibin-A are elevated, while AFP and u E 3 uE_3 u E 3 ​ are reduced.

Ultrasound Anomaly Scan (TIFFA / Level II Scan)

Performed at 18–22 weeks (ideal: 18–20 weeks). Systematically evaluates fetal anatomical structures (soft tissue markers, heart cardiac four-chamber view, spine, brain ventricles, kidneys, limbs) and placenta location.

  • 5. Fetal Well-Being & Surveillance Protocols
  • Daily Fetal Movement Count (DFMC)

Cardiff "Count to 10" Method: Patient counts fetal movements starting at 9:00 AM. A count of 10 movements within 12 hours indicates fetal well-being.

Sadovsky Method: Patient counts movements for 1 hour after meals. At least 4 movements in 1 hour (or 10 movements over 3 post-meal hours) is reassuring.

Non-Stress Test (NST)

Cardiotocography (CTG) monitoring of fetal heart rate (FHR) acceleration in response to fetal movements over a 20–40 minute window:

Reactive NST (Reassuring): Presence of ≥ 2 \ge 2 ≥ 2 FHR accelerations of at least 15 beats per minute (bpm) above baseline, lasting for at least 15 seconds within a 20-minute tracing (the 15 × \times × 15 rule for ≥ 32 \ge 32 ≥ 32 weeks; for < 32 <32 < 32 weeks, the 10 × \times × 10 rule applies).

Non-Reactive NST: Absence of adequate accelerations over 40 minutes. Indicates potential fetal hypoxia or fetal sleep cycle; requires further testing via Biophysical Profile (BPP) or Contraction Stress Test (CST).

Fetal Biophysical Profile (BPP / Manning Score)

Combines NST with real-time ultrasound parameters. Evaluates 5 parameters scored as either 2 (normal) or 0 (abnormal), giving a total score out of 10:

Non-Stress Test: Reactive NST = 2; Non-reactive = 0.

Fetal Breathing Movements: ≥ 1 \ge 1 ≥ 1 episode of rhythmic breathing lasting ≥ 30 \ge 30 ≥ 30 seconds within 30 minutes = 2.

Gross Body Movements: ≥ 3 \ge 3 ≥ 3 discrete body or limb movements in 30 minutes = 2.

Fetal Tone: ≥ 1 \ge 1 ≥ 1 episode of active extension with return to flexion of fetal limbs or hand = 2.

Amniotic Fluid Volume: At least 1 pocket of amniotic fluid measuring ≥ 2 cm \ge 2\text{ cm} ≥ 2 cm in two perpendicular planes (or Amniotic Fluid Index / AFI > 5 cm > 5\text{ cm} > 5 cm ) = 2.

  • BPP Score Clinical Interpretation & Action
  • 8/10 or 10/10 Normal, non-asphyxiated fetus; repeat test as indicated
  • 6/10 Equivocal; suspected fetal hypoxia; repeat test within 24 hours (or deliver if term)
  • 4/10 or Less Strongly predictive of fetal asphyxia; delivery indicated if fetus is viable

Pathophysiological Concept: Amniotic fluid volume reflects chronic placental functioning/hypoxia (decreased renal perfusion causes oligohydramnios). In contrast, FHR accelerations, breathing movements, body movements, and tone reflect acute fetal central nervous system status, compromised in that exact sequential order during acute hypoxia.

Loading diagram... Fetal Surveillance & Diagnostic Cascade